MAXWELL BRAUNSTEIN: Open Payments
NPI 1518501766 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 29 payments from 11 companies in 2025. Trend: 2023 $1,720 · 2024 $993 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $238 |
| Novo Nordisk Inc | 10 | $205 |
| Shockwave Medical, Inc | 1 | $176 |
| Sumitomo Pharma America, Inc. | 4 | $89 |
| PFIZER INC. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Dexcom, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Abbott Laboratories | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: ZEPBOUND, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Rybelsus, GEMTESA, Wegovy, JARDIANCE, MOUNJARO, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
